Financials
- Financial year
- 2026
- Total assets
- €31,671
- Profit
- €22,043
- Solvency
- 69.9%
Dr. Ines Lebbe
ActiveSummary
Dr. Ines Lebbe has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €22,143 and a net result of €22,043. Its solvency ranks better than 48% of 232 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€31,671total assets 2026
- Equity
- €22,143
- Profit
- €22,043
Turnover not published (micro format)
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.32, cash €5,663Figures for financial year 2026 (filed 28-09-2026)Equity €22,143 (69.9% of total assets)Show the evidence
Checked score
Score 2026
95
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 58% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency
95
equity 69.9% of total assets
Liquidity
60
short-term debt 30.1% · cash 17.9%
Profitability
100
return on assets 69.6%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.32, above the usual 1.5; short-term debt: 30.1% and cash: 17.9% of total assets), and 30.1% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 58% on solvency, 37% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 19-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 28-09-2026, 33 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2026
33 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2026 · micro…
- IncorporationAppointment: LEBBE Ines Anna (statutory…
Key points
By topic
Board & ownership
- Board
- 1 member
- LEBBE Ines AnnaDirector
Timeline
- Events
- 2
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 02-10-2025
- Year ends
- 31-03
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 25
- Purpose
- “De uitoefening van de geneeskunde met specialisatie Gynaecologie door de arts…” (deed in Dutch)
- Statutory auditor
- No statutory auditor
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.